New Proposals From the Research-Based Pharmaceutical Industry Should Reduce Inequalities in Patient Access to Medicines across Europe
Europe's pharmaceutical sector is stepping up measures to help deliver faster, more equitable access to medicines for millions of patients across the EU.
The new pledge from the European Federation of Pharmaceutical Industries and Associations (EFPIA) member companies should drastically increase the availability of innovative medicines in EU countries and decrease the time patients must wait for new medicines by several months.
From today EFPIA Member companies commit to file for pricing and reimbursement in all EU countries as soon as possible and no later than 2 years from the central EU market authorisation, provided that local systems allow it. The commitment is designed to help deliver faster, more equitable access to medicines for patients across Europe.
Data published by EFPIA last week showed that disparities in the time it takes for patients to access new medicines in different EU Member States are increasing. Patients in Germany wait around 133 days to access new medicines compared to patients in Romania that endure a wait of 899 days. Significant disparities also occurred in terms of availability of innovative medicines since less than 30% of centrally approved products are available in smaller and Eastern European Member States compared with 92% in Germany and 46% in average in the European Union.
Modelling by IQVIA predicts that the commitment to file would increase the availability of medicines from 18% up to 64% in several countries depending on the country’s payer resource for assessment of the increased number of applications. Critically, the modelling also estimates that the commitment would reduce the time patients wait for new medicines by 4 to 5 months in several countries such as Bulgaria (-179 days), Poland (-129 days) and Romania (-155 days).
However, the time between getting marketing authorisation and companies filing for pricing and reimbursement in a country is just one part of the story. According to analysis by Charles River Associates, there are 10 inter-related factors that cause barriers and delays in patients getting access to new medicines. These causes are rooted in Member States’ access systems and processes and their corresponding impact on commercial decision-making.
This is why the commitment to file is supported by the launch of an online portal where marketing authorisation holders can provide timely information regarding the timing and processing of pricing and reimbursement applications in the EU-27 countries. Bringing greater transparency to the barriers and delays to access will facilitate finding solutions in partnership. Further details of both the commitment to file and the online portal are included in Addressing patient inequalities in Europe, a position paper published by EFPIA today.
In addition to a more equitable system for patients, EFPIA is opening discussions on a more equitable system for EU Members States where the price of innovative medicines can vary between countries depending on their economic level and ability to pay. Also published today, a discussion document entitled ‘A Shared Approach to Supporting Equity-based Tiered Pricing’ sets out the key features of an equity-based tiered pricing system, anchored in the principle of solidarity between Member States and enshrined in the EU treaties. To deliver an equity based, fairer system requires the Commission and Member States to amend external reference pricing systems and undertake mechanisms to prevent the unintended consequences from internal trade in medicines.
Speaking about the launch of the new commitments, EFPIA Director General Nathalie Moll said. “By reducing the time it takes to file for pricing and reimbursement in all 27 EU member States, by bringing greater transparency to the barriers and delays to access, by co-creating an equity-based pricing system, by adopting an efficient system of EU assessments of relative efficacy and by sharing information on the implementation of novel pricing mechanisms, we believe that together we can create a step-change in the access landscape for patients across Europe.”
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Melanie Wahl, Acumen Public Affairs
+32 492 288717
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fabasoft Approve is now an autonomous limited liability company23.5.2022 17:05:00 EEST | Press release
Fabasoft Approve, the product for managing technical data and documents launched by software manufacturer Fabasoft and employed successfully in industry since 2019, became an independent company on April 27, 2022. Entrepreneur Andreas Dangl will assume the management of the new digitalization services company. As a defining leader in the Fabasoft Group, Dangl was responsible for the development of Fabasoft Cloud technology and was both the idea generator as well as the principal architect of software products including Fabasoft Approve. He is now pooling his expertise in the corporation based in Linz (Austria) with the express intention of re-imagining the digital world in mechanical and plant engineering and rendering it simpler to navigate. “Fabasoft Approve GmbH provides the perfect framework for meeting the needs of our industrial customers in an even more focused way. We have exciting times ahead of us, in which my team and I, together with our clients, will tap the innovative pot
“PUMA and the Land of Games”: New Virtual Place on Roblox for PUMA Fans to Connect and Compete23.5.2022 17:00:00 EEST | Press release
PUMA in partnership with Wonder Works studio launches a vibrant and immersive sports-based experience on Roblox, a global online platform connecting millions of people through shared experiences. PUMA and the Land of Games experience features Roblox newest Layered Clothing technology, where players can customize their characters with hyperrealistic clothing that fits any avatar body type to wear PUMA from head to toe. As they explore the experience, fans will unlock new zones and additional PUMA sportswear pieces. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220523005611/en/ PUMA in partnership with Wonder Works studio launches a vibrant and immersive sports-based experience on Roblox, a global online platform connecting millions of people through shared experiences. (Photo: Business Wire) “PUMA and the Land of Games” offers the global Roblox community to bring out their inner athlete through sports mini games and training
Fabrice Tocco, Dawex co-CEO, Speaking at the World Economic Forum Annual Meeting in Davos about Data Ecosystems to Respond to Competitiveness and Economic Sovereignty Challenges23.5.2022 16:40:00 EEST | Press release
Dawex, the leading technology company for data exchange, data marketplace and data hub, announced today that co-CEO Fabrice Tocco will be speaking at the World Economic Forum Annual Meeting in Davos, and will share his vision on creating new data exchange ecosystems to respond to environmental and economic challenges. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220523005654/en/ Live Session at Davos (Photo: Dawex) “Strengthening Trust in Public-Private Data Exchanges” Tuesday, May 24 at 13:30 CET Data ecosystems have become a fundamental component of business competitiveness and economic sovereignty. In today’s economy where data has become a product of unlimited potential, with its own value, and a source of new revenue streams, Dawex technology allows organizations to create new ecosystems around data exchange platforms that meet regulatory requirements and address traceability and security challenges. About Dawex In to
Daiichi Sankyo Europe highlights need to address the perception and classification of CVD risk with data presentations at EAS 202223.5.2022 16:15:00 EEST | Press release
Daiichi Sankyo Europe, (hereafter, Daiichi Sankyo) announced today multiple data presentations at the European Atherosclerosis Society (EAS) Congress 2022, highlighting the need to address current clinical perceptions and classification of risk of developing or exacerbating cardiovascular disease (CVD).1,2 Latest data from SANTORINI, a multinational, prospective, observational study designed to assess the management of high- and very high-risk CV patients requiring lipid-lowering therapy (LLT) in routine clinical practice, demonstrated that the CV risk of patients analysed was notably underestimated in clinical practice according to European guidelines.1,2,3 Data show that of the 9,044 patients analysed within the SANTORINI study 70.8% of patients were classified by the investigators as being at very high-risk and 29.2% as high-risk of heart attack or stroke. However, of those high-risk patients, 41.5% demonstrated evidence of atherosclerotic cardiovascular disease (ASCVD) which dictat
Coliseo De Puerto Rico and ASM Global Recognize 10,000,000th Visitor at Tommy Torres Concert23.5.2022 16:00:00 EEST | Press release
The Coliseo de Puerto Rico José Miguel Agrelot and ASM Global, the world’s largest producer of live entertainment experiences, surprised Melanie Biringer-Figueroa with the news of being the 10,000,000th visitor to the “Choli” as she made her entrance to the venue on Saturday to enjoy the Tommy Torres concert, “El Playlist de Anoche Live.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220523005410/en/ ASM Global’s Coliseo de Puerto Rico Jose Miguel Agrelot’s Jorge L. Pérez, CVE, regional manager of ASM Global, (center) and Mariela Vallines, executive director of the Puerto Rico Convention District Authority, (left) celebrate with fan Melanie Biringer-Figueroa (right) with news of Biringer-Figueroa being the revered venue’s 10,000 000th visitor this weekend. (Photo courtesy ASM Global). “We are overjoyed to be able to recognize our 10 millionth visitor and celebrate this historic and special moment with her,” said Jorge L. Pé
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom